September 2023
Doheny Closes out 75th Anniversary with Eyes on the Future
Last month marked the end of our 75th year, closing out a remarkable time for Doheny Eye Institute – from our founding by Carrie Estelle Doheny in 1947 after she lost the sight in her left eye to becoming one of the world’s foremost leaders in vision research.
We are now settled into our new Pasadena campus, which opened nearly two years ago, and broke ground earlier this month on our new Doheny Eye Center UCLA Pasadena Clinic which will be housed on the first floor of our campus in a spacious, state-of-the-art space.
Coming up in December we celebrate 10 years of affiliation with UCLA Stein Eye Institute, a remarkable partnership that furthers our goal to conserve, preserve and restore vision in all people.
It is through the generosity of our supporters that the researchers and clinician-scientists at Doheny are able to secure the equipment they need and critical funding to continue leading their field and supporting our efforts to preserve human eyesight. Our storied history and bright future are made possible by our donors, and we send our deepest gratitude to everyone who has supported us over the decades.
If you would like to support the future of Doheny Eye Institute, click here or call Molly Ann Woods at (323) 342-7111.
Doheny Again Ranks in the Top 5 Ophthalmology Hospitals in US News & World Report
Since 2013, Doheny and UCLA Stein Eye Institutes – two of the nation’s top eye institutes – have been united in an affiliation that improves patients’ access to leading vision specialists. We are thrilled to share that every year since this alliance began, Doheny and UCLA Stein Eye Institutes have together ranked in the Top 5 Ophthalmology Hospitals by US News & World Report. Read more here.
Steven Barnes, PhD, Selected to Receive Five-Year NIH Research Grant
Steven Barnes, PhD, Principal Investigator at Doheny Eye Institute and Professor of Ophthalmology and Neurobiology at UCLA’s David Geffen School of Medicine, was selected to receive a five-year grant from the National Institutes of Health (NIH) for his research on retinal ganglion cell signaling regulated by intrinsic reactive oxygen species. This grant is a shining example of the recognition that Doheny Eye Institute continues to receive for its innovative research. Read more here.
